- What they do
- Argenx is a biopharmaceutical company focused on immunology that discovers and develops treatments for autoimmune diseases. It serves patients with conditions including myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and immune thrombocytopenia.Taken from the employer’s own website. This is the company describing itself, not something we have verified.
- Approximate size
- Files full accountsFrom the accounts category filed at Companies House, not a headcount.
- Founded
- 11 August 2022Date of incorporation at Companies House, which is not always when trading began.
- Registered office
- SPACES GERRARDS CROSS, GERRARDS CROSS, SL9 0BG, UNITED KINGDOMThe address registered at Companies House. It is often an accountant’s office rather than a workplace.
- Filings
- Overdue: the confirmation statement was due 24 August 2026Late filing is common and not by itself a sign of trouble. It is shown because a company keeps its Active status for months after it stops trading, and its filings do not.